Bacil Pharma [BACPHAR] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Bacil Pharma Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bacil Pharma Ltd. wins in 3 metrics, Sun Pharmaceutical Industries Ltd. wins in 13 metrics, with 1 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bacil Pharma Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 118.00 36.73 Sun Pharmaceutical Industries Ltd.
Price-to-Book Ratio 3.09 5.15 Bacil Pharma Ltd.
Debt-to-Equity Ratio 0.00 6.68 Tie
PEG Ratio -0.91 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA -312.09 23.61 Sun Pharmaceutical Industries Ltd.
Profit Margin (TTM) 134.64% 19.21% Bacil Pharma Ltd.
Operating Margin (TTM) -39.22% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) N/A 26.17% N/A
Return on Equity 1.59% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 1.58% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $4.01M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return 10.61% 7.10% Bacil Pharma Ltd.
Price-to-Sales Ratio (TTM) 154.56 7.05 Sun Pharmaceutical Industries Ltd.
Enterprise Value $754.34M $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 137.68 6.66 Sun Pharmaceutical Industries Ltd.
Gross Profit Margin (TTM) N/A 80.96% N/A
Revenue per Share (TTM) $0 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $0.50 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.55 0.11 Sun Pharmaceutical Industries Ltd.

Bacil Pharma Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

BACPHAR
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bacil Pharma Ltd.-9.98%-20.59%-30.97%-19.51%0.92%5.05%
Sun Pharmaceutical Industries Ltd.-0.09%0.96%-3.84%1.28%0.50%4.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bacil Pharma Ltd.10.61%366.06%494.15%1,158.50%1,113.06%494.15%
Sun Pharmaceutical Industries Ltd.7.10%82.23%170.41%143.23%656.74%2,541.29%

Performance & Financial Health Analysis: Bacil Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBACPHARSUNPHARMA
Market Information
Market Cap i₹804.20M₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,5803,903,142
90 Day Avg. Volume i15,2933,253,866
Last Close₹39.31₹1,806.00
52 Week Range₹26.69 - ₹61.80₹1,548.00 - ₹1,916.60
% from 52W High-36.39%-5.77%
All-Time High₹62.56 (Dec 16, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-37.16%-7.87%
Growth Metrics
Quarterly Revenue GrowthN/A0.14%
Quarterly Earnings GrowthN/A0.16%
Financial Health
Profit Margin (TTM) i1.35%0.19%
Operating Margin (TTM) i-0.39%0.26%
Return on Equity (TTM) i0.02%0.15%
Debt to Equity (MRQ) i0.006.68
Cash & Liquidity
Book Value per Share (MRQ)₹19.09₹324.46
Cash per Share (MRQ)₹1.22₹115.87
Operating Cash Flow (TTM) i₹3.94M₹110.84B
Levered Free Cash Flow (TTM) i₹4.04M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Bacil Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBACPHAR (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i118.0036.73
Forward P/E iN/A29.48
PEG Ratio i-0.913.59
Price to Sales (TTM) i154.567.05
Price to Book (MRQ) i3.095.15
Market Capitalization
Market Capitalization i₹804.20M₹3.88T
Enterprise Value i₹754.34M₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i137.686.66
Enterprise to EBITDA i-312.0923.61
Risk & Other Metrics
Beta i0.550.11
Book Value per Share (MRQ) i₹19.09₹324.46

Financial Statements Comparison: Bacil Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBACPHAR (2025)SUNPHARMA (2025)
Revenue/Sales i0520.41B
Cost of Goods Sold i0121.98B
COGS % of Revenue i-23.4%
Gross Profit i0398.44B
Gross Margin i-76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i-1.87M125.81B
Operating Margin i-24.2%
EBITDA i-1.29M167.25B
EBITDA Margin i-32.1%
Pre-Tax Income i4.08M137.52B
Pre-Tax Income % of Revenue i-26.4%
Income Tax i34,46027.72B
Income Tax % of Revenue i-5.3%
Net Income (Profit) i4.04M109.65B
Profit Margin i-21.1%

Balance Sheet & Liquidity Metrics

MetricBACPHAR (2025)SUNPHARMA (2025)
Cash & Equivalents i28.57M102.69B
Total Current Assets i29.07M526.24B
Total Current Assets % of Revenue i-101.1%
Total Current Liabilities i1.69M181.94B
Total Current Liabilities % of Revenue i-35.0%
Long-Term Debt iN/A3.58B
Long-Term Debt % of Revenue i-0.7%
Total Shareholders Equity i254.31M724.86B
Retained Earnings i114.61M578.62B
Retained Earnings % of Revenue i-111.2%
Property, Plant & Equipment iN/A100.36B

Cash Flow Statement Comparison

MetricBACPHAR (2025)SUNPHARMA (2025)
Operating Cash Flow i3.94M110.84B
Operating Cash Flow % of Revenue i-21.3%
Capital Expenditures i0-20.68B
Free Cash Flow i4.01M119.44B
FCF Margin i-23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricBACPHARSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i14.35M2.40B
Float Shares i3.93M1.07B
% Held by Insiders i81.03%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i18.97%15.69%

Dividend Analysis & Yield Comparison: Bacil Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBACPHARSUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026